Barclays analyst Eliana Merle reiterated an Equalweight rating and $25.00 price target on uniQure BV (NASDAQ: QURE).The analyst comments "QURE ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Hot Comments

Mizuho on uniQure BV (QURE): 'expressed confidence the overall signal — namely the slowing of disease progression — should remain directionally consistent'June 17, 2026 1:27 PM uniQure BV (QURE) PT Raised to $71 at StifelJune 17, 2026 9:31 AM